Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients

Nephrology Dialysis Transplantation

Volumn 13, Issue 10, 1998, Pages 2605-2611

  Caravaca, Francisco ^a   Fernández, María A ^a   Ruiz Calero, Rosa ^a   Cubero, Juan ^a   Aparicio, Angel ^a   Jimenez, Francisca ^a   García, María C ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Hyperparathyroidism; Kidney transplantation; Phosphate; Secondary; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; BICARBONATE; CALCIFEDIOL; CALCITRIOL; CALCIUM; CREATININE; PHOSPHORUS; URIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGRAFT; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HUMAN; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MINERAL METABOLISM; ORAL DRUG ADMINISTRATION; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; URIC ACID BLOOD LEVEL; URINALYSIS; VITAMIN BLOOD LEVEL;

ADMINISTRATION, ORAL; CALCITRIOL; CALCIUM; CALCIUM CHANNEL AGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MICRONUTRIENTS; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PHOSPHORUS; PROSPECTIVE STUDIES; TRACE ELEMENTS; VITAMIN D;

EID: 0031695336     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.10.2605     Document Type: Article

References (32)

1. de Francisco AM, Riancho JA, Amado JA et al. Calcium, hyperparathyroidism and vitamin D metabolism after kidney transplantation. Transplant Proc 1987; 19: 3721-3723
2. Lobo PI, Cortez MS, Stevenson W, Pruett TL. Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Transplant 1995, 9: 277-281
3. Dumoulin G, Hory B, Nguyen NU et al. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnorver in normocalcemic long-term renal transplant recipients. Am J Kidney Dis 1997; 29: 746-753
4. Nehine D, Rondeau E, Paillard F et al. Aseptic necrosis of bone following renal transplantation: relationship with hyperparathyroidism. Nephrol Dial Transplant 1989; 4: 123-128
5. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544-550
6. Tanaka Y, DeLuca HF: The control of 1,25-dihydroxyvitamin D metabolism by inorganic phophorus. Arch Biochem Biophys 1973; 154: 566-574
7. Portale AA, Booth BE, Halloran BP, Morris BC Jr. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984; 73: 1580-1589
8. Portale AA, Halloran BP, Morris RC Jr. Physiologic regulation of the serum concentrations of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 1989; 83: 1494-1499
9. Tessitori NA, Venturi A, Adami S et al. Relationship between plasma vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. Miner Electrolyte Metab 1987; 13: 38-44
10. Rodriguez M, Martín-Malo A, Martinez ME, Torres A, Felsenfeld AJ, Llach F. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effects on calcitriol. Kidney Int 1991; 40: 1055-1062
11. Slatopolsky E, Finch J, Denda M et al. Phosphorus restriction prevents parathyroid gland overgrowth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-2540
12. Hernandez A, Conceptión MT, Rodriguez M, Salido E, Torres A. High phosphorus diet increases preproPTH mRNA independent of calcium and calcitriol in normal rats. Kidney Int 1996; 50: 1872-1878
13. Almaden Y, Canalejo A, Hernandez A et al. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 1996; 11: 970-976
14. Nielsen PK, Feldt-Rassmussen U, Olgaard K. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 1996; 11: 1762-1768
15. Lund B, Sorensen OH, Bishop JE, Norman AW. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man. J Clin Endocrinol Metab 1980; 50: 480-483
16. Prince RL, Hutchinson BO, Dick I. The regulation of calcitriol by parathyroid hormone and absorbed dietary phosphorus in subjects with moderate chronic renal failure. Metabolism 1993; 42: 834-838
17. 2 vitamin D3 in response to parathryroid hormone in patients with incipient renal failure. Nephron 1991; 57: 314-318
18. 2D levels in renal disease. Kidney Int 1983; 24: 104-109
19. Prince RL, Hutchinson BG, Kent JC, Retallack RW. Calcitriol deficiency with retained synthetic reserve in chronic renal failure. Kidney Int 1988; 33: 722-728
20. Hsu CH, Patel SR. Uremic plasma contains factors inhibiting 1-alpha-hydroxylase activity. J Am Soc Nephrol 1992; 3: 947-952
21. Parfitt AM. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 1982; 8:92-112
22. Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phopshate and vitamin D. J Clin Invest 1995; 96: 1786-1793
23. Parfitt AM. The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int 1997; 52: 3-9
24. Broadus AE, Magee JS, Mallette LE et al. A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1983; 56: 953-961
25. Fensenfeld AJ, Gutman RA, Drezner M, Llach F. Hypophosphatemia in long-term renal transplant recipients: effect on bone histology and 1,25-dihydroxycholecalciferol. Miner Electrolyte Metab 1986; 12: 333-341
26. Steiner RW, Ziegler M, Halasz NA, Catherwood BD, Manolagas S, Deftos U. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxyvitamin D on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation 1993; 56: 843-846
27. Saha HHT, Salmela KT, Ahonen PJ et al. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scand J Urol Nephrol 1994; 28: 21-27
28. Garabedian M, Silve C, Levy-Bentolila D et al. Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children. Kidney Int 1981; 20: 403-410
29. Krapf R, Glatz M, Hulter HN. Neutral phosphate administration generates and maintains renal metabolic alkalosis and hyperparathyroidism. Am J Physiol 1995; 268 (Pt 2): F802-807
30. Hulter HN, Toto RD, Ilnicki LP, Halloran B, Sebastian A. Metabolic alkalosis in models of primary and secondary hyperparathyroid states. Am J Physiol 1983; 245: F450-461
31. Kilav R, Silver J, Naveh-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 1995; 96: 327-333
32. Tallon S, Berdud I, Hernandez A et al. Relative effects of PTH and dietary phosphorus on calcitriol production in normal and azotemic rats. Kidney Int 1996; 49: 1441-1446